Literature DB >> 17014930

Norepinephrine acts as D1-dopaminergic agonist in the embryonic avian retina: late expression of beta1-adrenergic receptor shifts norepinephrine specificity in the adult tissue.

Regina Celia Cussa Kubrusly1, Ana Lúcia Marques Ventura, Ricardo Augusto de Melo Reis, Gracinda Conceição Fernandes Serra, Edna Nanami Yamasaki, Patrícia Franca Gardino, Maria Christina Fialho de Mello, Fernando Garcia de Mello.   

Abstract

Dopamine is the main catecholamine found in the chick retina whereas norepinephrine is only found in trace amounts. We compared the effectiveness of dopamine and norepinephrine in promoting cyclic AMP accumulation in retinas at embryonic day 13 (E13) and from post-hatched chicken (P15). Dopamine (EC(50)=10microM) and norepinephrine (EC(50)=30microM), but not the beta(1)-adrenergic agonist isoproterenol, stimulated over seven-fold the production of cyclic AMP in E13 retina. The cyclic AMP accumulation induced by both catecholamines in embryonic tissue was entirely blocked by 2microM SCH23390, a D(1) receptor antagonist, but not by alprenolol (beta-adrenoceptor antagonist). In P15 retinas, 100microM isoproterenol stimulated five-fold the accumulation of cAMP. This effect was blocked by propanolol (10microM), but not by 2microM SCH23390. Embryonic and adult retina display beta(1) adrenergic receptor mRNA as detected by RT-PCR, but the beta(1) adrenergic receptor protein was detected only in post-hatched tissue. We conclude that norepinephrine cross-reacts with D(1) dopaminergic receptor with affinity similar to that of dopamine in the embryonic retina. In the mature retina, however, D(1) receptors become restricted to activation by dopamine. Moreover, as opposed to the embryonic tissue, norepinephrine seems to stimulate cAMP accumulation via beta(1)-like adrenergic receptors in the mature tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17014930     DOI: 10.1016/j.neuint.2006.08.004

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory.

Authors:  Kimberly A Kempadoo; Eugene V Mosharov; Se Joon Choi; David Sulzer; Eric R Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-07       Impact factor: 11.205

3.  Dexamphetamine effects on separate constructs in the rubber hand illusion test.

Authors:  Matthew A Albrecht; Mathew T Martin-Iverson; Greg Price; Joseph Lee; Rajan Iyyalol; Flavie Waters
Journal:  Psychopharmacology (Berl)       Date:  2011-03-23       Impact factor: 4.530

4.  Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

Authors:  Luca Filippi; Giacomo Cavallaro; Patrizio Fiorini; Marta Daniotti; Valentina Benedetti; Gloria Cristofori; Gabriella Araimo; Luca Ramenghi; Agostino La Torre; Pina Fortunato; Liliana Pollazzi; Giancarlo la Marca; Sabrina Malvagia; Paola Bagnoli; Chiara Ristori; Massimo Dal Monte; Anna Rita Bilia; Benedetta Isacchi; Sandra Furlanetto; Francesca Tinelli; Giovanni Cioni; Gianpaolo Donzelli; Silvia Osnaghi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2010-11-18       Impact factor: 2.125

5.  Catecholaminergic Innervation of the Lateral Nucleus of the Cerebellum Modulates Cognitive Behaviors.

Authors:  Erik S Carlson; Avery C Hunker; Stefan G Sandberg; Timothy M Locke; Julianne M Geller; Abigail G Schindler; Steven A Thomas; Martin Darvas; Paul E M Phillips; Larry S Zweifel
Journal:  J Neurosci       Date:  2021-02-03       Impact factor: 6.709

Review 6.  The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery.

Authors:  Annette Gower; Mario Tiberi
Journal:  Front Synaptic Neurosci       Date:  2018-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.